Adverum Biotechnologies Inc. (ADVM)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 0 |
Ownership rank: | -- |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
3 |
$1,439,088 |
Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
28 Feb 2025 |
LEONARD BRADEN MICHAEL |
10% |
28 Feb 2025 |
85,068 |
4.60 |
391,015 |
28 Feb 2025 |
LEONARD BRADEN MICHAEL |
10% |
27 Feb 2025 |
86,802 |
4.46 |
387,094 |
28 Feb 2025 |
LEONARD BRADEN MICHAEL |
10% |
26 Feb 2025 |
164,886 |
4.01 |
660,979 |
31 Jul 2024 |
LEONARD BRADEN MICHAEL |
10% |
30 Jul 2024 |
85,800 |
7.15 |
613,470 |
18 Jul 2024 |
LEONARD BRADEN MICHAEL |
10% |
18 Jul 2024 |
80,718 |
9.11 |
735,736 |
18 Jul 2024 |
LEONARD BRADEN MICHAEL |
10% |
17 Jul 2024 |
135,546 |
7.75 |
1,049,926 |
09 Feb 2024 |
SCOPA JAMES PAUL |
Director |
07 Feb 2024 |
100,000 |
1.35 |
135,000 |
09 Feb 2024 |
LUPHER, JR. MARK L. |
Director |
07 Feb 2024 |
130,000 |
1.35 |
175,500 |
09 Jun 2023 |
RUBINSTEIN LINDA M |
Chief Financial Officer |
07 Jun 2023 |
100,000 |
1.45 |
145,490 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock